People · Operator
Named in public records as an officer, director or promoter · active 2015–2026 · Other, Other Health Care, Healthtech, AI / ML, Software / Tech, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Emboline Inc | — | Other | Series C | $66.9M | $795.4M | 2020 |
| Laplace Interventional, Inc. | — | Other Health Care | Series B | $42.0M | $114.8M | 2023 |
| Luminopia, Inc. | — | Other Health Care | Series B | $36.5M | $142.0M | 2022 |
| Early Bird Medical, Inc. | — | Healthtech | Series A | $26.6M | $21.8M | 2022 |
| Huma.AI, Inc. | — | AI / ML | Series A | $15.0M | $4.4M | 2019 |
| NeuroVasc Technologies, Inc. | — | Software / Tech | Series A | $7.1M | $115.4M | 2015 |
| Rila Therapeutics, Inc. | — | Biotechnology | Series A | $7.0M | $29.2M | 2024 |
| Apostle, Inc. | — | Biotechnology | Seed | $3.3M | $148.0M | 2019 |
WILLIAM DAI at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside WILLIAM DAI on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Langer | 1 | 36 |
| Andrew Schwab | 1 | 16 |
| Casey Tansey | 1 | 14 |
| John Crumpler | 1 | 7 |
| Amir Belson | 1 | 6 |
| J. Casey McGlynn | 1 | 5 |
| Michael Wallace | 1 | 5 |
| Lu Zhang | 1 | 5 |
| Tony Natale | 1 | 5 |
| JEFF PETERS | 1 | 4 |
| Karen Drexler | 1 | 4 |
| Steve Skolsky | 1 | 4 |
| Nicholas Pappas | 1 | 4 |
| Joi Ito | 1 | 4 |
| Elton Satusky | 1 | 4 |
| Jeffrey Dunn | 1 | 3 |
| Peng Cheng | 1 | 3 |
| Jason Keiser | 1 | 3 |
| James Han | 1 | 3 |
| Skott Greenhalgh | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.